You know XIENCE as the world's leading drug-eluting stent (DES), with an unparalleled safety record.1 The XIENCE safety heritage is now further strengthened with XIENCE Sierra’s exceptional acute performance. XIENCE Sierra continues to provide unparalleled safety1 along with enhanced deliverability for even the most complex percutaneous coronary interventions (PCI). Learn more about what XIENCE Sierra offers for even the most complex patients.
The Science Behind XIENCE Sierra

XIENCE Sierra features an ultra-low crossing profile* (0.0390″) that provides excellent deliverability. This newest generation XIENCE stent also offers expanded treatment options: 5.5 mm maximum post expansion.#
The Science Behind XIENCE Sierra

XIENCE Sierra features an ultra-low crossing profile (0.0390″) that provides excellent deliverability. This newest generation XIENCE stent also offers expanded treatment options: 5.5 mm maximum post expansion.#
XIENCE Safety For Complex PCI

Multiple recent XIENCE trial results, with endpoints ranging from 1 to 3 years,4-7 reveal excellent safety data on stent thrombosis (ST) in left main disease, diabetes and other complex conditions.
Xience Safety For Complex PCI

Multiple recent XIENCE trial results, with endpoints ranging from 1 to 3 years,4-7 reveal excellent safety data on stent thrombosis (ST) in left main disease, diabetes and other complex conditions.
Experts' and Patient's point of view
“I thought, ’How lucky am I, on top of everything else, to have had XIENCE to help me continue to live my life to the fullest?’ ”
Alec R., triathlete and
cyclist, patient treated for
chronic total occlusion (CTO)
“I thought, ’How lucky am I, on top of everything else, to have had XIENCE to help me continue to live my life to the fullest?’ ”
Alec R., triathlete and
cyclist, patient treated for
chronic total occlusion (CTO)
Get the Latest Data
AP2944530-WBO Rev. C